Glenmark Pharmaceuticals Shares Rise for Third Consecutive Session Amid Market Gains
Glenmark Pharmaceuticals Ltd shares rose for a third consecutive session, trading at Rs 2,260.5 with a 2.24 increase as of 12:49 IST on the NSE. The stock has gained 21.53% over the past year, outperforming the NIFTY, which declined 4.02%, and the Nifty Pharma index, down 15.14%. Over the last month, Glenmark's stock rose 3.86%, while the Nifty Pharma index increased 6.64%. Trading volume was 3.7 lakh shares, below the one-month daily average of 5.9 lakh. The stock's price-to-earnings ratio stands at 38.97 based on trailing twelve months earnings ending March 26.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. Coverage leans balanced overall (Left 0%, Centre 100%, Right 0%). Overall sentiment is positive (70/100). Lens Score 30/100 — low public interest.
Outlets analysed (first-hand measurement by TBN's Bias Engine):
- businessstandard— balanced framing, positive sentiment
- businessstandard— balanced framing, positive sentiment
AI Analysis
The articles focus on financial performance and stock market data without political framing. Coverage centers on market metrics, comparing Glenmark Pharmaceuticals' stock movements with broader indices. There is no evident political perspective or partisan interpretation, reflecting a purely economic and business-oriented viewpoint.
The tone across the articles is positive, highlighting Glenmark Pharmaceuticals' stock gains over various periods and its outperformance relative to market indices. The sentiment is factual and optimistic regarding the company's market performance, without exaggeration or negative commentary.
How 2 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.